Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In advance of the 'Reflections on 60th anniversary of the Hinchliffe Report' Symposium, Liz Morrell, Senior Researcher at the Health Economics Research Centre (HERC), Nuffield Department of Population Health (NDPH) explores the discussion of the report in parliament in a new Oxford Science Blog.

Plus ça change: pharmaceutical spending in the NHS © Shutterstock

In 1957, the UK National Health Service (NHS) was just nine years old and already grappling with a very familiar problem – the rising cost of prescriptions. The drug bill at the time was £57 million, compared to the £17.4 billion spend in 2017 – clearly a different era. In June 1957, the government tasked the Committee on the Cost of Prescribing, led by Sir Henry Hinchliffe, to investigate, resulting in the Cost of Prescribing (Hinchliffe) report.

On 11 November 2019, the Health Economics Research Centre (HERC) is presenting a symposium to mark the 60th anniversary of the document. The report made a set of landmark recommendations, and the symposium will explore, 60 years on, what has changed. Do we face similar challenges today? What long-term recommendations to address the current challenges could be made by the government?

Many of the recommendations in the Hinchliffe report related to the generation, interpretation, and use of evidence on drug efficacy. These included recommendations on medical training, to include education on economical prescribing, and training to enable doctors to evaluate manufacturers’ claims for their drugs. The report accepts the importance of pharmaceutical industry investment in research and development, but wishes to curb “extravagant sales propaganda, some of which is undesirable”! Further, the report argues for establishment of a permanent expert body “to include men with business experience, an economist and a statistician” to advise on drug costs – presumably women were not invited to apply to be part of this forerunner of NICE?

As a member of the organising group for the symposium, I wanted to find out more about the discussion of the report in parliament, and delved into Hansard, the official record of UK Parliament proceedings. Surprisingly, given the subsequent impact of the report’s ideas, there is little mention of it. The report is mentioned in a debate on prescription charges on 13 July 1959, in which the Minister of Health, Derek Walker-Smith, describes the report as “a factor to be taken into account in the consideration of the relevant circumstances to which I then referred” – hardly a ringing endorsement.

Read more (Oxford Science Blog)

Find out more about the Symposium (HERC website)

Similar stories

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.